Xcelerate (XCRT) Stock Price, News & Analysis

Company Overview

Xcelerate Inc. acquires engineering/patents and applies to early-stage medical technology companies. The company engages in the formulation, packaging and marketing of consumer health and beauty, and clinically tested skin care products; development of artificial intelligence and virtual health technology to assist patients; owning and licensing the rights to various forms of medical equipment. It also provides Ceramedx, a natural plant based therapeutic skin care product; Earth Science Beauty, which offers natural facial skincare targeted to specific skin types. The company was formerly known as Union Dental Holdings, Inc. and changed its name to Xcelerate Inc. Xcelerate Inc. was incorporated in 1996 is based in Mauldin, South Carolina.

Key Stats

• Today's Range: $0.02 to $0.03
• 50-Day Range: $0.01 to $0.03
• 52-Week Range: $0.01 to $0.06
• Volume: 60,533 shs
• Average Volume: 188,225 shs
• Market Capitalization: $11.84 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

XCRT Stock Analysis - Frequently Asked Questions

How have XCRT shares performed this year?

Xcelerate's stock was trading at $0.0360 at the beginning of 2024. Since then, XCRT stock has decreased by 24.3% and is now trading at $0.0273.
View the best growth stocks for 2024 here.

How do I buy shares of Xcelerate?

Shares of XCRT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Xcelerate own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Xcelerate investors own include BioTech Medics (BMCS), Artificial Intelligence Technology Solutions (AITX), Elys BMG Group (ELYS), Foresight Autonomous (FRSX), GNCC Capital (GNCP), GBT Technologies (GTCH) and Sorrento Therapeutics (SRNE).

Company Calendar

• Today: 11/28/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Health services
• Sub-Industry: Healthcare
• Current Symbol: OTCMKTS:XCRT
• CUSIP: N/A
• CIK: 1138586
• Web: newudhi.com
• Phone: (854) 900-2020
• Fax: N/A
• Employees: 24
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 434,450,000
• Free Float: N/A
• Market Cap: $11.84 million
• Optionable: Not Optionable
• Beta: 3.03